Abstract 140: Effect of Transendocardial Autologous Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and Restore Cardiac Function in a Heart Failure Swine Model

Background: A cell combination of human mesenchymal stem cells (MSCs) and c-kit+ cardiac stem cells (CSCs) improves left ventricular (LV) performance to a greater degree than MSCs alone in post…

Continue ReadingAbstract 140: Effect of Transendocardial Autologous Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and Restore Cardiac Function in a Heart Failure Swine Model

Arterial regeneration and clinical improvement of secondary autoimmune Raynaud’s syndrome with autologous bone marrow mononuclear cells (aBM-MNC). early results of phase II clinical trial

Raynaud phenomenon is chronic vasospasm of the fingers, ears, nose and toes that occurs in response to stress or cold exposure, with a prevalence rates of 11% in women and…

Continue ReadingArterial regeneration and clinical improvement of secondary autoimmune Raynaud’s syndrome with autologous bone marrow mononuclear cells (aBM-MNC). early results of phase II clinical trial

Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis

Mesenchymal stem cells (MSCs) are multipotent cells with the capacity to undergo chondrogenic differentiation. Systemically administered MSCs have been shown to preferentially accumulate at sites of tissue damage and inflammation,…

Continue ReadingHoming of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis